Invention Grant
US08642661B2 Pharmaceutical combinations of beta-3 adrenergic receptor agonists and muscarinic receptor antagonists
有权
β-3肾上腺素能受体激动剂和毒蕈碱受体拮抗剂的药物组合
- Patent Title: Pharmaceutical combinations of beta-3 adrenergic receptor agonists and muscarinic receptor antagonists
- Patent Title (中): β-3肾上腺素能受体激动剂和毒蕈碱受体拮抗剂的药物组合
-
Application No.: US13196068Application Date: 2011-08-02
-
Publication No.: US08642661B2Publication Date: 2014-02-04
- Inventor: Stephen Caltabiano , Eliot Ohlstein , Stewart McCallum
- Applicant: Stephen Caltabiano , Eliot Ohlstein , Stewart McCallum
- Applicant Address: US PA Glenmoore
- Assignee: Altherx, Inc.
- Current Assignee: Altherx, Inc.
- Current Assignee Address: US PA Glenmoore
- Agency: Fox Rothschild LLP
- Main IPC: A01N33/02
- IPC: A01N33/02 ; A61K31/135 ; A01N33/00 ; A61K31/13 ; A61K31/16 ; A01N43/04 ; A61K31/70
Abstract:
Pharmaceutical combinations comprising a beta-3 adrenergic receptor agonist and a muscarinic receptor antagonist, and methods for their use are disclosed. Disclosed combinations include solabegron and oxybutynin. Methods of using the pharmaceutical combinations for the treatment of one or more symptoms associated with overactive bladder, for example, frequency of urgency, nocturia, and urinary incontinence, are also disclosed.
Public/Granted literature
- US20120035118A1 PHARMACEUTICAL COMBINATIONS Public/Granted day:2012-02-09
Information query
